Mucomyst Related Published Studies
Well-designed clinical trials related to Mucomyst (Acetylcysteine Inhalation)
N-Acetylcysteine as adjunctive treatment in severe malaria: A randomized, double-blinded placebo-controlled clinical trial. [2009.12.26]
Intravenous N-acetylcysteine improves transplant-free survival in early stage non-acetaminophen acute liver failure. [2009.09]
A phase II study on safety and efficacy of high-dose N-acetylcysteine in patients with cystic fibrosis. [2009.08.12]
Effect of N-acetylcysteine on air trapping in COPD: a randomized placebo-controlled study. [2009.08]
N-acetylcysteine, a glutamate modulator, in the treatment of trichotillomania: a double-blind, placebo-controlled study. [2009.07]
Potentially detrimental effects of N-acetylcysteine on renal function in knee arthroplasty. [2009.07]
Effects of N-acetylcysteine on semen parameters and oxidative/antioxidant status. [2009.07]
N-acetylcysteine does not prevent contrast-induced nephropathy after cardiac catheterization in patients with diabetes mellitus and chronic kidney disease: a randomized clinical trial. [2009.06.29]
N-acetylcysteine is associated with increased blood loss and blood product utilization during cardiac surgery. [2009.06]
N-acetylcysteine versus AScorbic acid for preventing contrast-Induced nephropathy in patients with renal insufficiency undergoing coronary angiography NASPI study-a prospective randomized controlled trial. [2009.03]
The role of glutathione-S-transferase polymorphisms on clinical outcome of ALI/ARDS patient treated with N-acetylcysteine. [2009.03]
N-acetylcysteine as adjunctive treatment in severe malaria: a randomized, double-blinded placebo-controlled clinical trial. [2009.02]
Effects of N-acetylcysteine on respiratory muscle fatigue during heavy exercise. [2009.01.01]
Meta-analysis of N-acetylcysteine to prevent acute renal failure after major surgery. [2009.01]
Blood cardioplegia with N-acetylcysteine may reduce coronary endothelial activation and myocardial oxidative stress. [2009.01]
Nephrotoxic effects of iodixanol and iopromide in patients with abnormal renal function receiving N-acetylcysteine and hydration before coronary angiography and intervention: a randomized trial. [2009.01]
N-acetylcysteine improves arterial vascular reactivity in patients with chronic kidney disease. [2009]
Poorly controlled type 1 diabetes is associated with altered glutathione homeostasis in adolescents: apparent resistance to N-acetylcysteine supplementation. [2008.12]
The effects of low dose N-acetylcysteine (NAC) as an adjunct to cardioplegia in coronary artery bypass surgery. [2008.12]
Is treatment with N-acetylcysteine to prevent contrast-induced nephropathy when using bicarbonate hydration out of date? [2008.12]
N-acetylcysteine improves the clinical conditions of mustard gas-exposed patients with normal pulmonary function test. [2008.11]
Effect of N-acetylcysteine administration on intraoperative plasma levels of interleukin-4 and interleukin-10 in liver transplant recipients. [2008.11]
N-acetylcysteine supplementation and oxidative damage and inflammatory response after eccentric exercise. [2008.08]
Effects of intravenous N-acetylcysteine on periprocedural myocardial injury after on-pump coronary artery by-pass grafting. [2008.08]
Meta-analysis of N-Acetylcysteine to Prevent Acute Renal Failure After Major Surgery. [2008.07.21]
Inhaled thiamphenicol and acetylcysteine in children with acute bacterial rhinopharyngitis. [2008.07]
Clinical outcomes of contrast-induced nephropathy in patients undergoing percutaneous coronary intervention: a prospective, multicenter, randomized study to analyze the effect of hydration and acetylcysteine. [2008.06.06]
Randomized, blinded, placebo-controlled clinical trial of N-acetylcysteine in dogs with spinal cord trauma from acute intervertebral disc disease. [2008.06.01]
Randomized, blinded, placebo-controlled clinical trial of N-acetylcysteine in dogs with spinal cord trauma from acute intervertebral disc disease. [2008.06.01]
Utility of N-acetylcysteine to prevent acute kidney injury after cardiac surgery: a randomized controlled trial. [2008.06]
N-acetylcysteine and fenoldopam protect the renal function of patients with chronic renal insufficiency undergoing cardiac surgery. [2008.05]
N-Acetylcysteine does not artifactually lower plasma creatinine concentration. [2008.05]
Long-term N-acetylcysteine and L-arginine administration reduces endothelial activation and systolic blood pressure in hypertensive patients with type 2 diabetes. [2008.05]
Improved estimation of glomerular filtration rate by serum cystatin C in preventing contrast induced nephropathy by N-acetylcysteine or zinc--preliminary results. [2008.04]
Intravenous N-acetylcysteine during hemodialysis reduces asymmetric dimethylarginine level in end-stage renal disease patients. [2008.01]
N-acetylcysteine for prevention of acute renal failure in patients with chronic renal insufficiency undergoing cardiac surgery: a prospective, randomized, clinical trial. [2008.01]
The effect of N-acetylcysteine on proteinuria and markers of tubular injury in non-diabetic patients with chronic kidney disease. A placebo-controlled, randomized, open, cross-over study. [2008]
Effects of folic acid and N-acetylcysteine on plasma homocysteine levels and endothelial function in patients with coronary artery disease. [2007.12]
N-acetylcysteine for preventing acute kidney injury in cardiac surgery patients with pre-existing moderate renal insufficiency. [2007.11]
N-acetylcysteine for prevention of acute renal failure in patients with chronic renal insufficiency undergoing cardiac surgery: A prospective, randomized, clinical trial* [2007.10.16]
Randomised, double blind, placebo controlled trial of intravenous antioxidant (n-acetylcysteine, selenium, vitamin C) therapy in severe acute pancreatitis. [2007.10]
Sodium bicarbonate, N-acetylcysteine, and saline for prevention of radiocontrast-induced nephropathy. A comparison of 3 regimens for protecting contrast-induced nephropathy in patients undergoing coronary procedures. A single-center prospective controlled trial. [2007.09]
I.v. N-acetylcysteine and emergency CT: use of serum creatinine and cystatin C as markers of radiocontrast nephrotoxicity. [2007.09]
N-acetylcysteine reduces urinary albumin excretion following contrast administration: evidence of biological effect. [2007.09]
Improvement by N-acetylcysteine of acute respiratory distress syndrome through increasing intracellular glutathione, and extracellular thiol molecules and anti-oxidant power: evidence for underlying toxicological mechanisms. [2007.09]
Gentamicin-induced ototoxicity in hemodialysis patients is ameliorated by N-acetylcysteine. [2007.08]
Effects of N-acetylcysteine against systemic and renal hemodynamic effects of endotoxin in healthy humans. [2007.08]
Phase II, randomized, controlled trial of high-dose N-acetylcysteine in high-risk cardiac surgery patients. [2007.05]
Efficacy of N-acetylcysteine and hydration versus placebo and hydration in decreasing contrast-induced renal dysfunction in patients undergoing coronary angiography with or without concomitant percutaneous coronary intervention. [2007.05]
The reno-protective effect of hydration with sodium bicarbonate plus N-acetylcysteine in patients undergoing emergency percutaneous coronary intervention: the RENO Study. [2007.03.27]
Randomized, double-blind, placebo-controlled trial of Intravenous (n-acetylcysteine, selenium, vitamin c) Antioxidant therapy in severe acute pancreatitis. [2007.03.13]
A randomized controlled trial comparing hydration therapy to additional hemodialysis or N-acetylcysteine for the prevention of contrast medium-induced nephropathy : The Dialysis-versus-Diuresis (DVD) Trial. [2007.03]
Intravenous N-acetylcysteine for preventing contrast-induced nephropathy: a randomised trial. [2007.01.31]
Effect of intravenous N-acetylcysteine on outcomes after coronary artery bypass surgery: a randomized, double-blind, placebo-controlled clinical trial. [2007.01]
Increased hydrogen peroxide concentration in the exhaled breath condensate of stable COPD patients after nebulized N-acetylcysteine. [2007]
A randomized controlled trial comparing hydration therapy to additional hemodialysis or N-acetylcysteine for the prevention of contrast medium-induced nephropathy : The Dialysis-versus-Diuresis (DVD) Trial. [2006.12.22]
Effects of acetylcysteine and ischaemic preconditioning on muscular function and postoperative pain after orthopaedic surgery using a pneumatic tourniquet. [2006.12]
Preclinical trial of L-arginine monotherapy alone or with N-acetylcysteine in septic shock. [2006.11]
Lack of renoprotective effect of i.v. N-acetylcysteine in patients with chronic renal failure undergoing cardiac surgery. [2006.11]
Cysteine, cystine or N-acetylcysteine supplementation in parenterally fed neonates. [2006.10.18]
N-acetylcysteine attenuates the decline in muscle Na+,K+-pump activity and delays fatigue during prolonged exercise in humans. [2006.10.01]
Does N-acetylcysteine prevent contrast-induced nephropathy during endovascular AAA repair? A randomized controlled pilot study. [2006.10]
The role of N-acetylcysteine in lower extremity ischemia/reperfusions. [2006.10]
Clinical use of evidence-based medicine--clinical questions: Acetylcysteine, a new treatment for an old foe? [2006.09]
Lack of protection of N-acetylcysteine (NAC) in acute renal failure related to elective aortic aneurysm repair-a randomized controlled trial. [2006.07]
Oral N-acetylcysteine administration does not stabilise the process of established severe preeclampsia. [2006.07]
N-acetylcysteine and contrast-induced nephropathy in primary angioplasty. [2006.06.29]
N-acetylcysteine does not prevent post-endoscopic retrograde cholangiopancreatography hyperamylasemia and acute pancreatitis. [2006.06.21]
N-acetylcysteine for the prevention of kidney injury in abdominal aortic surgery: a randomized, double-blind, placebo-controlled trial. [2006.06]
Prophylaxis of contrast material-induced nephropathy in patients in intensive care: acetylcysteine, theophylline, or both? A randomized study. [2006.06]
Comparison of N-acetylcysteine and fenoldopam for preventing contrast-induced nephropathy (CAFCIN). [2006.05.24]
Acetylcysteine In Diabetes (AID): a randomized study of acetylcysteine for the prevention of contrast nephropathy in diabetics. [2006.05]
The role of N-acetylcysteine in the prevention of contrast-induced nephrotoxicity. [2006.05]
N-acetylcysteine has neuroprotective effects against oxaliplatin-based adjuvant chemotherapy in colon cancer patients: preliminary data. [2006.05]
Efficacy of the antioxidant N-acetylcysteine (NAC) in protecting ears exposed to loud music. [2006.04]
Cardioprotective effect of cold-blood cardioplegia enriched with N-acetylcysteine during coronary artery bypass grafting. [2006.02]
The effect of N-acetylcysteine on blood coagulation and platelet function in patients undergoing open repair of abdominal aortic aneurysm. [2006.01]
Safety and tolerability of N-acetylcysteine in cocaine-dependent individuals. [2006.01]
N-acetylcysteine and contrast-induced nephropathy: a meta-analysis of 13 randomized trials. [2006.01]
Intravenous N-acetylcysteine during haemodialysis reduces the plasma concentration of homocysteine in patients with end-stage renal disease. [2006]
High-dose acetylcysteine in idiopathic pulmonary fibrosis. [2005.11.24]
A pilot study of aerosolized N-acetylcysteine for idiopathic pulmonary fibrosis. [2005.09]
Superoxide scavenging effects of N-acetylcysteine and vitamin C in subjects with essential hypertension. [2005.08]
Perioperative N-acetylcysteine to prevent renal dysfunction in high-risk patients undergoing cabg surgery: a randomized controlled trial. [2005.07.20]
N-acetylcysteine does not prevent contrast induced nephropathy after cardiac catheterisation with an ionic low osmolality contrast medium: a multicentre clinical trial. [2005.06]
Effects of N-acetylcysteine on outcomes in chronic obstructive pulmonary disease (Bronchitis Randomized on NAC Cost-Utility Study, BRONCUS): a randomised placebo-controlled trial. [2005.04.30]
Effects of N-acetylcysteine on microalbuminuria and organ failure in acute severe sepsis: results of a pilot study. [2005.04]
The Australasian Clinical Toxicology Investigators Collaboration randomized trial of different loading infusion rates of N-acetylcysteine. [2005.04]
[Antioxidant treatment with N-acetylcysteine and vitamin C in patients with chronic bronchitis] [2005.03.18]
Effectiveness of acetylcysteine in prevention of contrast nephropathy. [2005.02]
Long-term oral n-acetylcysteine reduces exhaled hydrogen peroxide in stable COPD. [2005]
Well-designed clinical trials possibly related to Mucomyst (Acetylcysteine Inhalation)
The contrast media and nephrotoxicity following coronary revascularization by primary angioplasty for acute myocardial infarction study: design and rationale of the CONTRAST-AMI study. [2009.10.13]
The role of cystine-glutamate exchange in nicotine dependence in rats and humans. [2009.05.15]
Aerosol antibiotic therapy in children with chronic upper airway infections: a potential alternative to surgery. [2009.04]
Comparison of the effect of propofol and N-acetyl cysteine in preventing ischaemia-reperfusion injury. [2009.04]
Preventing contrast-induced nephropathy in patients with baseline renal dysfunction undergoing coronary angiography. [2009.02]
Efficacy of selenium and/or N-acetyl-cysteine for improving semen parameters in infertile men: a double-blind, placebo controlled, randomized study. [2009.02]
Hyperbaric oxygen, oxidative stress, NO bioavailability and ulcer oxygenation in diabetic patients. [2009.01]
Effect of oral N-acetyl cysteine on recurrent preterm labor following treatment for bacterial vaginosis. [2009.01]
A pilot study evaluating surfactant on eustachian tube function in divers. [2008.12]
Predictors for contrast media-induced nephropathy and long-term survival: prospectively assessed data from the randomized controlled Dialysis-Versus-Diuresis (DVD) trial. [2008.11]
|
